$ENZ to $2.94 LONG - Monthly setup is strong3/16/23 - Enzo Biochem (ENZ) stock is rising higher on an asset sale agreement.
It’s selling its Clinical Laboratory division to Labcorp (LH).
3/20/23 - Monthly GD on MC.
8/23/23 - $3 per share.
ENZ trade ideas
$ENZ is gonna fall todayPupm&Dump trading strategy idea.
$ENZ is rising too much today.
The demand for shares of the company looks lower than the supply.
This and other conditions can cause a fall in the share price today.
So I opened a short position from $3,48;
stop-loss — $3,67;
take-profit — $3,12.
Do not view this idea as a recommendation for trading or investing. It is published only to introduce my own vision.
Always do your own analysis before making deals. When you use any materials, do not rely on blind trust.
You should remember that isolated deals do not give systematic profit, so trade/invest using a developed strategy.
If you like my content, you can subscribe to the news and receive my fresh ideas.
Thanks for being with me!
Enzo Biochem spiked on 43x average volumeEnzo Biochem spiked on 43x average volume. This is highly volatile price action. Enzo Biochem (ENZ) reported Quarter January 2021 earnings of $0.09 per share on revenue of $31.5 million. Revenue grew 62.3% on a year-over-year basis. Enzo Biochem Inc is engaged in research, development, manufacturing and marketing of health care products, platforms and services. The Company provides clinical laboratory services. ENZ proprietary system for detection of the coronavirus SARS-CoV-2 is GENFLEX.
breakout = $4.56
R3 = $4.36
R2 = $4.16
R1 = $3.99
pivot = $3.73
S1 = $3.60
S2 = $3.41
S3 = $3.22
break down = $3.04
Do your own due diligence, your risk is 100% your responsibility. You win some or you learn some. Consider being charitable with some of your profit to help humankind. Small incremental steps work : If you double a penny a day for a month it = $5,368,709. Good luck and happy trading friends...
*3x lucky 7s of trading*
7pt Trading compass:
Price action, entry/exit
Volume average/direction
Trend, patterns, momentum
Newsworthy current events
Revenue
Earnings
Balance sheet
7 Common mistakes:
+5% portfolio trades, risk management
Beware of analysts motives
Emotions & Opinions
FOMO : bad timing
Lack of planning & discipline
Forgetting restraint
Obdurate repetitive errors, no adaptation
7 Important tools:
Trading View app!, Brokerage UI
Accurate indicators & settings
Wide screen monitor/s
Trading log (pencil & graph paper)
Big organized desk
Reading books, playing chess
Sorted watch-list
Checkout my indicators:
Fibonacci VIP - volume
Fibonacci MA7 - price
pi RSI - trend momentum
TTC - trend channel
AlertiT - notification
www.tradingview.com
ENZ Spike Higher After FDA EUA For Its AMPIPROBEShares Of Enzo Life Sciences Spike Higher After Co. Gets FDA Emergency Use Authorization For Its AMPIPROBE Coronavirus Test System
Enzo Biochem (NYSE:ENZ) soared 21% yesterday as its Ampiprobe SARS-CoV-2 Test System was granted Emergency Use Authorization by the FDA in a letter.
The letter stated, "based on the totality of scientific evidence available to FDA, it is reasonable to believe that your product may be effective in diagnosing COVID-19, and that the known and potential benefits of your product when used for diagnosing COVID-19, outweigh the known and potential risks of your product."
www.fda.gov
seekingalpha.com
ENZ just getting noticed -not your typical stupid Corona coThis is the real deal from a fundamental perspective 1.00 in cash no debt, activist bought 12% of co. and put 2 people on the board before Corona ever became a thing and they bought their 12% position at $3.07 , 400 patents 80mm in revenue and insiders have bought between 2.20-3.65 - oh and yes as a side note their involved in corona testing as well. Much safer fundamental play on Corona .... oh one last thing their in the process of possibly spinning off their therapeutic business and just reported a good quarter last weel.
ENZO BIOCHEM INC - NYSE: $ENZ FlaggingLast week, ENZO BIOCHEM INC - NYSE:ENZ broke to higher ground and in the process, recaptured its 200 DMA out of a rounding bottom and now finds itself digesting/consolidating the move within a Flag pattern on lower volume as is evidenced in the Daily chart above.
In addition, ENZ is now trading above all of its important moving averages 20/50/200 DMA's and finds itself in fine technical shape.
Moving forward, both investors/traders may want to continue to monitor the action with a close eye. Specifically, should ENZ be capable of going topside of the $4.50 figure, such development would likely trigger its next advance with a primary objective in the $5-$6 zone with a secondary potential objective at $7 further down the road.
Nevertheless, investors/traders may want to put ENZ front-and-center on their radars.
Double bottom, next stop $5. Fib lines show next price targets.Nice play here. THere might be a slight pullback mid week, and wait to confirm candle closes above previous highs before entering. Ichi on the daily is big time bullish for the first time in a LONG TIME.
ENZ on watch.Double bottom on the weekly, could very easily hit 4.90 this week. Confirmed buy the breakout past 4.20. Price Target #2 would be 5.43.
ENZ Showing Bullish Flag With Strong FundamentalsEnzo Biochem has been in a strong uptrend since mid-2015 and has solid fundamentals to boot. More recently, the stock has been digesting its big gains in a consolidation flag pattern and is poised to break out to the upside within the next week or two. We want to be long ENZ, **IF AND ONLY IF** it breaks the upper resistance line of the flag pattern. Our short term target is $12.50 with room to head up to $16 if you let it ride.
ENZ GOING FOR ONE MORE WAVE UP?ENZ is making a huge spike to the upside after the strong operating results. I'm expecting more upside for this one.
